Abstract
In this issue of the Journal, Sibley etal. (2017) presented some important insights into how different assessment approaches influence the apparent persistence of ADHD into adulthood, while Swanson etal. (2017) presented interesting results regarding the long-term benefits (adult symptom reduction) and costs (adult height suppression) associated with the treatment of ADHD with stimulant medication. This commentary highlights that (a) future studies that attempt to explore the occurrence and predictors of persisting and remitting developmental trajectories of ADHD, as well as late-onset ADHD, need to be based on thorough assessment of ADHD in adulthood using a combination of self-ratings and other informants (parents), and that (b) observational studies of the long-term benefits and risk associated with ADHD medications will play an important role in future research and clinical guidelines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
